In the case of tau protein, 9 differential targets were detected in early AD stages, whereas 18 and 19 targets constituted the differential Tau interactome in intermediate and advanced AD stages respectively (Fig. 5 and Supplementary Fig. 4). This evidence concerns the gene MAPT and Alzheimer disease.